INTERNATIONAL PATENT: HOTSPOT THERAPEUTICS, INC. FILES APPLICATION FOR "COMBINATION CBL-BI AND ANTIHISTAMINE FOR CANCER THERAPY"

GENEVA, March 19 -- HOTSPOT THERAPEUTICS, INC. (1 Design Center PlaceSuite 19-600Boston, MA 02210) filed a patent application (PCT/US2025/045152) for "COMBINATION CBL-BI AND ANTIHISTAMINE FOR CANCER THERAPY" on Sep 05, 2025. With publication no. WO/2026/055492, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QI, Yilin (c/o HotSpot Therapeutics, Inc.One Design Center Place, Suite 19-600Boston, MA 02210), WANG, Fang (c/o HotSpot Therapeutics, Inc.One Design Center Place, Suite 19-600Boston, MA 02210), HARRIMAN, Geraldine, C...